Prevention and treatment of noninfectious complications in patients under peritoneal dialysis

doi:10.3877/cma.j.issn.2095-3216.2016.03.005

Abstract

Abstract:

Peritoneal dialysis (PD) has been widely applied for treating patients with end-stage renal disease, and the number of long-term PD patients has continuously increased. Noninfectious complications are emerging as an important cause for technique failure of PD, including catheter-related complications, increased intra-abdominal pressure-related complications, and metabolic complications. Active prevention and treatment of these noninfectious complications are important for improving the outcomes of PD patients.

Key words: Peritoneal dialysis, Noninfectious complications, Prevention, Treatment

Wei Fang, Yaorong Liu. Prevention and treatment of noninfectious complications in patients under peritoneal dialysis[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2016, 05(03): 114-117.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2016.03.005

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2016/V05/I03/114

References 35

[1]	Lo WK. Peritoneal dialysis in the Far East-an astonishing situation in 2008[J]. Perit Dail Int, 2009, 29 (Suppl 2): 227-229.
[2]	Cho Y,Johnson DW. Peritoneal dialysis-related peritonitis: towards improving evidence, practices, and outcomes[J]. Am J Kidney Dis, 2014, 64(2): 278-289.
[3]	Leung CB,Cheung WL,Li PK. Renal registry in Hong Kong-the first 20 years[J]. Kidney Int Suppl, 2015, 5(1): 33-38.
[4]	Schaubel DE,Blake PG,Fenton SSA. Trends in CAPD technique failure: Canada 1981-1997[J]. Perit Dial Int, 2001, 21(4): 365-371.
[5]	Mujais S,Story K. Peritoneal dialysis in the US: Evaluation of outcomes in contemporary cohorts[J]. Kidney Int Suppl, 2006, 103: S21-S26.
[6]	Fang W,Qian J,Lin A, et al. Comparison of peritoneal dialysis practice patterns and outcomes between a Canadian and a Chinese centre[J]. Nephrol Dial Transplant, 2008, 23(12): 4021-4028.
[7]	Liu Y,Zhang L,Lin A, et al. Impact of break-in period on the short-term outcomes of patients started on peritoneal dialysis[J]. Peri Dial Int, 2014, 34(1): 49-56.
[8]	Figueiredo A,Goh BL,Jenkins S, et al. Clinical practice guidelines for peritoneal access[J]. Perit Dial Int, 2010, 30(4): 424-429.
[9]	Gadallah MF,Mignone J,Torres C, et al. The role of peritoneal dialysis catheter configuration in preventing catheter tip migration[J]. Adv Perit Dial, 2000, 16: 47-50.
[10]	Flanigan M,Gokal R. Peritoneal catheters and exit-site practices toward optimum peritoneal access: a review of current developments[J]. Perit Dial Int, 2005, 25(2): 132-139.
[11]	Crabtree JH,Burchette RJ,Siddiqi NA. Optimal peritoneal dialysis catheter type and exit site location: an anthropometric analysis[J]. ASAIO J, 2005, 51(6): 743-747.
[12]	Oqünç G,Tuncer M,Oqünç D, et al. Laparoscopic omenal fixation technique versus open surgical placement of peritoneal dialysis catheters[J]. Surg Endosc, 2003, 17(11): 1749-1755.
[13]	Crabtree JH. Development of surgical guidelines for laparoscopic peritoneal dialysis access: down a long and winding road[J]. Perit Dial Int, 2015, 35(3): 241-244.
[14]	Tu WT,Su Z,Shan YS. An original non-traumatic maneuver for repositioning migrated peritoneal dialysis catheters[J]. Perit Dial Int, 2009, 29(3): 325-329.
[15]	Zorzanello MM,Fleming WJ,Prowant BE. Use of tissue plasminogen activator in peritoneal dialysis catheters: A literature review and one center′s experience[J]. Nephrol Nurs J, 2004, 31(5): 534-537.
[16]	王琴,倪兆慧,朱铭力, 等. 腹腔CT影像学检查在腹膜透析相关非感染性腹腔并发症中的诊断价值[J]. 中西医结合学报, 2008, 6(5): 478-481.
[17]	Bargman JM. Complications of peritoneal dialysis related to increased intraabdominal pressure[J]. Kidney Int Suppl, 1993, 40: S75-S80.
[18]	Garcia-Urena MA,Rodriguez CR,Vega Ruiz, et al. Prevalence and management of hernias in peritoneal dialysis patients[J]. Perit Dial Int, 2006, 26(2): 198-202.
[19]	Crabtree JH. Hernia repair without delay in initiation or continuing peritoneal dialysis[J]. Perit Dial Int, 2006, 26(2): 178-182.
[20]	Shah H,Chu M,Bargman JM. Perioperative management of peritoneal dialysis patients undergoing hernia surgery without the use of interim hemodialysis[J]. Perit Dial Int, 2006, 26(6): 684-687.
[21]	Bargman JM. Hernias in peritoneal dialysis patients: limiting occurrence and recurrence[J]. Perit Dial Int, 2008, 28(4): 349-351.
[22]	卞正乾,钟鸣,林爱武, 等. 腹膜透析病人合并腹壁疝的临床诊治体会[J]. 外科理论与实践, 2009, 14(4): 415-419.
[23]	Yoon CY,Lee Mj,Kee YK, et al. Insulin resistance is associated with new-onset cardiovascular events in nondiabetic patients undergoing peritoneal dialysis[J]. Kidney Res Clin Pract, 2014, 33(4): 192-198.
[24]	Cao L,Mou S,Fang W, et al. Hyperleptinaemia, insulin resistance and survival in peritoneal dialysis patients[J]. Nephrology (Carlton), 2015, 20(9): 617-624.
[25]	Selby NM,Fialova J,Burton JO, et al. The haemodynamic and metabolic effects of hypertonic-glucose and amino-acid based peritoneal dialysis fluids[J]. Nephrol Dial Transplant, 2007, 22(3): 870-879.
[26]	Bernardo AP,Oliveira JC,Santos O, et al. Insulin resistance in nondiabetic peritoneal dialysis patients: associations with body composition, peritoneal transport, and peritoneal glucose absorption[J]. Clin J Am Soc Nephrol, 2015, 10(12): 2205-2012.
[27]	Szeto CC,Chow KM,Kwan BC, et al. New-onset hyperglycemia in nondiabetic Chinese patients started on peritoneal dialysis[J]. Am J Kidney Dis, 2007, 49(4): 524-532.
[28]	Oba T,Mori T,Chida M, et al. Glucose and insulin response to Peritoneal dialysis fluid in diabetic and nondiabetic peritoneal dialysis patients[J]. Adv Perit Dial, 2015, 31: 11-16.
[29]	Wallace AM,McMahon AD,Packard CJ, et al. Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)[J]. Circulation, 2001, 104(25): 3052-3056.
[30]	Kim DJ,Oh DJ,Kim B, et al. The effect of continuous ambulatory peritoneal dialysis on change in serum leptin[J]. Perit Dial Int, 1999, 19(Suppl 2): S172-S175.
[31]	Teta D,Tedjani A,Burnier M, et al. Glucose-containing peritoneal dialysis fluids regulate leptin secretion from 3T3-L1 adipocytes[J]. Nephrol Dial Transplant, 2005, 20(7): 1329-1335.
[32]	Moberly JB,Mujais S,Gehr T, et al. Pharmacokinetics of icodextrin in peritoneal dialysis patients[J]. Kidney Int Suppl, 2002, 81: S23-S33.
[33]	Furuya R,Odamaki M,Kumagai H, et al. Beneficial effects of icodextrin on plasma levels of adipocytokines in peritoneal dialysis patients[J]. Nephrol Dial Transplant, 2006, 21(2): 494-498.
[34]	Little J,Phillips I,Russel I, et al. Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factor[J]. J Am Soc Nephrol, 1998, 9(10): 1931-1939.
[35]	Li PK,Culleton BF,Ariza A, et al. Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients[J]. J Am Soc Nephrol, 2013, 24(11): 1889-1900.

Please choose a citation manager

Content to export